Oxford BioMedica wins second $100 million gene therapy contract – Reuters
City A.M. |
Oxford BioMedica wins second $100 million gene therapy contract
Reuters The deal follows a similar $100 million contract last year to supply lentiviral vectors, which are used to deliver DNA into cells, for Novartis’s pioneering leukemia treatment Kymriah. Oxford Bio, which listed in London in 1996 after being spun out of … Oxford BioMedica share price rises on $100m gene therapy deal with BioverativCity A.M. Oxford BioMedica signs agreement with BioverativStock Market Wire Oxford BioMedica Inks Potential USD100 Million Deal With BioverativLondon South East (blog) Proactive Investors UK all 9 news articles » |
Germiston City News |
Stem cell therapy and storage a new healthcare revolution
Germiston City News The GCN spoke to Erna West, the general manager and a product specialist for CryoSave, South Africa’s leading stem cell storage company about the options available to parents regarding storing their baby’s umbilical cord stem cells at birth to help … |
Futurity: Research News |
Fruit fly stem cells offer glimpse of ‘perpetual life’
Futurity: Research News Researchers have discovered that sperm-producing fruit fly stem cells use a genetic trick to stay perpetually young across generations. Certain sections of the fruit fly genome get shorter with age, but, remarkably, some reproductive cells can repair … |